Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

10.1111/1742-6723.13537 http://scihub22266oqcxt.onion/10.1111/1742-6723.13537 32378805!7267590!32378805     free     free     free Deprecated: Implicit conversion from float 211.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 211.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 211.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534       Emerg+Med+Australas 2020 ; 32 (4): 697-699 Nephropedia Template TP {{tp|p=32378805|t=2020. COVID-19 and toxicity from potential treatments: Panacea or poison |pdf=|usr=}}{{32378805}} gab.com Text COVID-19 and toxicity from potential treatments: Panacea or poison JO: Emerg Med Australas http://www.kidney.de/pget.php?&tw=1&pmid=32378805 #FOAvip Since December 2019, coronavirus disease (COVID-19) has been increasingly spreading from its origin in Wuhan, China to many countries around the world eventuating in morbidity and mortality affecting millions of people. This pandemic has proven to be a challenge given that there is no immediate cure, no vaccine is currently available and medications or treatments being used are still undergoing clinical trials. There have already been examples of self-medication and overdose. Clearly, there is a need to further define the efficacy of treatments used in the management of COVID-19. This evidence needs to be backed by large randomised-controlled clinical trials. In the meantime, there will no doubt be further off-label use of these medications by patients and practitioners and possibly related toxicity. Twit Text FOAVip COVID-19 and toxicity from potential treatments: Panacea or poison ????Emerg Med Australas http://www.kidney.de/pget.php?&tw=1&pmid=32378805 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=32378805 #FOAvip English Wikipedia <ref>{{Cite pmid|32378805}}</ref> COVID-19 and toxicity from potential treatments: Panacea or poison #MMPMID32378805 Wong A Emerg Med Australas 2020[Aug]; 32 (4): 697-699 PMID32378805show ga Since December 2019, coronavirus disease (COVID-19) has been increasingly spreading from its origin in Wuhan, China to many countries around the world eventuating in morbidity and mortality affecting millions of people. This pandemic has proven to be a challenge given that there is no immediate cure, no vaccine is currently available and medications or treatments being used are still undergoing clinical trials. There have already been examples of self-medication and overdose. Clearly, there is a need to further define the efficacy of treatments used in the management of COVID-19. This evidence needs to be backed by large randomised-controlled clinical trials. In the meantime, there will no doubt be further off-label use of these medications by patients and practitioners and possibly related toxicity. |Antiviral Agents/therapeutic use/*toxicity[MESH] |Azithromycin/therapeutic use/toxicity[MESH] |Betacoronavirus/drug effects[MESH] |COVID-19[MESH] |COVID-19 Drug Treatment[MESH] |Chloroquine/therapeutic use/toxicity[MESH] |Coronavirus Infections/*drug therapy[MESH] |Humans[MESH] |Hydroxychloroquine/therapeutic use/toxicity[MESH] |Pandemics[MESH] |Pneumonia, Viral/*drug therapy[MESH] |Randomized Controlled Trials as Topic[MESH] |SARS-CoV-2[MESH]COVID-19 and toxicity from potential treatments: Panacea or poison (epmc).pdf DeepDyve Pubget Overpricing